Skip to main content
Clinical Trials/RPCEC00000405
RPCEC00000405
Recruiting
未知

Evaluation of Clinical Performance in a Maternity Hospital of the NEURONIC/INFANTIX Neonatal Screening System A6.2 - ECPMHNINSS

Cuban Neurosciences Center0 sites300 target enrollmentStarted: April 27, 2022Last updated:

Overview

Phase
未知
Status
Recruiting
Sponsor
Cuban Neurosciences Center
Enrollment
300

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Non-randomized controlled trial. Masking: Single Blind. Control group: Active. Assignment: Other. Purpose: Screening

Eligibility Criteria

Ages
2 days to 14 days (—)
Sex
All

Inclusion Criteria

  • 1\- All newborns with corrected age from 0 to 2 weeks and with more than 48 hours of birth will be included in the study.
  • 2\- The newborns included in the study must have the express voluntary acceptance (informed consent) of the parents or guardians.

Exclusion Criteria

  • 1\- Those newborns with some serious pathology that prevents their manipulation in that period are excluded from the study.

Investigators

Sponsor
Cuban Neurosciences Center

Similar Trials